JP7463764B2 - Liquid leakage prevention device and liquid introduction circuit blocking device - Google Patents

Liquid leakage prevention device and liquid introduction circuit blocking device Download PDF

Info

Publication number
JP7463764B2
JP7463764B2 JP2020031367A JP2020031367A JP7463764B2 JP 7463764 B2 JP7463764 B2 JP 7463764B2 JP 2020031367 A JP2020031367 A JP 2020031367A JP 2020031367 A JP2020031367 A JP 2020031367A JP 7463764 B2 JP7463764 B2 JP 7463764B2
Authority
JP
Japan
Prior art keywords
circuit
introduction
introduction liquid
blood
liquid circuit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020031367A
Other languages
Japanese (ja)
Other versions
JP2021132850A (en
Inventor
毅 櫃田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2020031367A priority Critical patent/JP7463764B2/en
Publication of JP2021132850A publication Critical patent/JP2021132850A/en
Application granted granted Critical
Publication of JP7463764B2 publication Critical patent/JP7463764B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本開示は、漏液抑制装置および導入液回路閉塞装置に関する。 This disclosure relates to a leakage suppression device and an introduction liquid circuit blocking device.

慢性腎不全の患者に施される血液透析治療が従来から知られている。血液透析治療とは、シャントと呼ばれる人工的に血流を増加させた血管部分より、留置針を用いて取り出した患者の血液を数時間かけて血液回路で対外循環させ、人工腎臓(ダイヤライザ)内で浄化および水分調整し、その後に患者の体内に戻す治療法である。 Hemodialysis is a treatment method that is used for patients with chronic renal failure. Hemodialysis is a treatment method in which the patient's blood is extracted using an indwelling needle from a blood vessel in which blood flow is artificially increased, called a shunt, and circulated extracorporeally in a blood circuit for several hours, purified and hydrated in an artificial kidney (dialyzer), and then returned to the patient's body.

血液透析治療において、患者の腕に刺された針からの液漏れが生じた場合、素早く対処することが求められる。特開2007-143895号公報(特許文献1)には、漏血等の液漏れが少量であっても検出することが可能な水分感知シートが開示されている。 In hemodialysis treatment, if fluid leaks from the needle inserted into the patient's arm, it is necessary to deal with the problem quickly. JP 2007-143895 A (Patent Document 1) discloses a moisture-sensing sheet that can detect even small amounts of fluid leakage, such as blood leakage.

特開2007-143895号公報JP 2007-143895 A

特許文献1に記載の発明では、穿刺部からの液漏れが検知されたという情報を知らせるために、感知シートが音源や発信装置等の付属機器に接続される。これにより、看護師等に容易に情報が伝達されると特許文献1では説明されている。液漏れの情報が伝達された看護師等が血液ポンプを停止させることで血液の循環が停止される。しかしながら、液漏れを効果的に抑制する観点からは、血液の循環停止までをさらに迅速に行なうことが要請される。 In the invention described in Patent Document 1, the sensor sheet is connected to accessory devices such as a sound source and a transmitter to inform the patient that leakage from the puncture site has been detected. Patent Document 1 explains that this allows the information to be easily transmitted to nurses, etc. The nurses, etc. who have received the information about the leakage can stop the blood pump, thereby stopping the blood circulation. However, from the perspective of effectively suppressing leakage, it is necessary to stop the blood circulation even more quickly.

本開示は、患者の体外に設けられ、上記患者の体内に導入される導入液が流れる導入液回路を含むシステムにおいて、液漏れ発生時に導入液の循環停止までを迅速に行ない、効果的に漏液を抑制することができる漏液抑制装置および導入液回路閉塞装置を提供することを目的とする。 The present disclosure aims to provide a leakage suppression device and an introduction liquid circuit blocking device that can quickly stop the circulation of the introduction liquid when a leakage occurs and effectively suppress leakage in a system that includes an introduction liquid circuit that is provided outside the patient's body and through which the introduction liquid to be introduced into the patient's body flows.

本開示に係る漏液抑制装置は、患者の体外に設けられ、上記患者の体内に導入される導入液が流れる導入液回路を含むシステムに用いられる漏液抑制装置であって、穿刺部における漏液または針抜状態を検知可能な検知部と、上記導入液回路上に設けられ、上記導入液回路を開閉可能な開閉機構と、上記穿刺部における漏液または針抜状態が上記検知部により検知されたときに、上記開閉機構により上記導入液回路を閉塞するように上記開閉機構を制御する制御部とを備える。 The leakage prevention device according to the present disclosure is a leakage prevention device for use in a system that is provided outside the patient's body and includes an introduction liquid circuit through which the introduction liquid to be introduced into the patient's body flows, and includes a detection unit capable of detecting leakage at the puncture section or a needle removal state, an opening/closing mechanism that is provided on the introduction liquid circuit and is capable of opening and closing the introduction liquid circuit, and a control unit that controls the opening/closing mechanism so that the opening/closing mechanism closes the introduction liquid circuit when leakage at the puncture section or a needle removal state is detected by the detection unit.

一つの実施態様では、上記漏液抑制装置において、上記開閉機構が上記導入液回路を閉塞したときの上記導入液回路の圧力の変動に基づいて、上記導入液回路に導入液を循環させる導入液ポンプが停止する。 In one embodiment, in the leakage prevention device, the introduction liquid pump that circulates the introduction liquid through the introduction liquid circuit is stopped based on the fluctuation in pressure in the introduction liquid circuit when the opening and closing mechanism closes the introduction liquid circuit.

一つの実施態様では、上記漏液抑制装置において、上記開閉機構は、上記導入液ポンプよりも上記導入液回路の上流側に設けられる。 In one embodiment, in the leakage suppression device, the opening and closing mechanism is provided upstream of the introduction liquid circuit from the introduction liquid pump.

一つの実施態様では、上記漏液抑制装置において、上記開閉機構は、第1面を有する第1部材と、上記第1面とほぼ平行な第2面を有する第2部材と、上記第2部材と対向する部分を有する第3部材と、上記第1部材と上記第2部材との間に設けられ、上記第1面と上記第2面とを近づける方向に上記第1部材および上記第2部材を付勢する弾性部材と、上記第3部材における上記第2部材と対向する部分が上記第2部材に近づく方向に上記第3部材を駆動可能な駆動部とを含み、通常時において、上記弾性部材の付勢力により上記第1面と上記第2面との間に上記導入液回路は保持され、上記穿刺部における漏液または針抜状態が上記検知部により検知されたとき、上記第3部材が駆動され、上記第2部材と上記第3部材とで上記導入液回路を挟持して上記導入液回路を閉塞するように、上記制御部が上記駆動部を制御する。 In one embodiment, in the leakage suppression device, the opening and closing mechanism includes a first member having a first surface, a second member having a second surface substantially parallel to the first surface, a third member having a portion facing the second member, an elastic member provided between the first member and the second member and biasing the first member and the second member in a direction to bring the first surface and the second surface closer together, and a drive unit capable of driving the third member in a direction in which the portion of the third member facing the second member approaches the second member. Under normal circumstances, the introduction liquid circuit is held between the first surface and the second surface by the biasing force of the elastic member, and when leakage or a needle removal state at the puncture portion is detected by the detection unit, the third member is driven, and the control unit controls the drive unit so that the introduction liquid circuit is sandwiched between the second member and the third member to close the introduction liquid circuit.

一つの実施態様では、上記漏液抑制装置において、上記第1面および上記第2面は各々2箇所に分けて形成される。 In one embodiment, in the leakage prevention device, the first surface and the second surface are each formed in two separate locations.

一つの実施態様では、上記漏液抑制装置において、上記導入液回路は、上記患者の血液が流れる血液回路を含む。 In one embodiment, in the leakage prevention device, the introduction fluid circuit includes a blood circuit through which the patient's blood flows.

一つの実施態様では、上記漏液抑制装置において、上記システムは、上記血液回路に接続されたダイアライザを含む人工透析システムである。 In one embodiment, in the leakage prevention device, the system is an artificial dialysis system including a dialyzer connected to the blood circuit.

本開示に係る導入液回路閉塞装置は、患者の体外に設けられ、上記患者の体内に導入される導入液が流れるた導入液回路を閉塞可能な導入液回路閉塞装置であって、第1面を有する第1部材と、上記第1面とほぼ平行な第2面を有する第2部材と、上記第2部材と対向する部分を有する第3部材と、上記第1部材と上記第2部材との間に設けられ、上記第1面と上記第2面とを近づける方向に上記第1部材および上記第2部材を付勢する弾性部材と、上記第3部材における上記第2部材と対向する部分が上記第2部材に近づく方向に上記第3部材を駆動可能な駆動部とを含み、上記導入液回路が上記第1面と上記第2面との間に保持された状態から、上記第3部材が駆動され、上記第2部材と上記第3部材とで上記導入液回路を挟持して上記導入液回路を閉塞する。 The introduction liquid circuit blocking device according to the present disclosure is an introduction liquid circuit blocking device that is provided outside the patient's body and is capable of blocking an introduction liquid circuit through which introduction liquid to be introduced into the patient's body flows, and includes a first member having a first surface, a second member having a second surface substantially parallel to the first surface, a third member having a portion facing the second member, an elastic member provided between the first member and the second member and biasing the first member and the second member in a direction to bring the first surface and the second surface closer together, and a drive unit capable of driving the third member in a direction in which the portion of the third member facing the second member approaches the second member, and the third member is driven from a state in which the introduction liquid circuit is held between the first surface and the second surface, and the introduction liquid circuit is sandwiched between the second member and the third member to block the introduction liquid circuit.

一つの実施態様では、上記導入液回路閉塞装置において、上記導入液回路は、上記患者の血液が流れる血液回路を含む。 In one embodiment, in the introduction fluid circuit occlusion device, the introduction fluid circuit includes a blood circuit through which the patient's blood flows.

本開示によれば、患者の体外に設けられた導入液回路を含むシステムにおいて、液漏れ発生時に導入液の循環停止までを迅速に行ない、効果的に漏液を抑制することができる。 According to the present disclosure, in a system including an introduction fluid circuit installed outside the patient's body, when a fluid leak occurs, the circulation of the introduction fluid can be stopped quickly, and leakage can be effectively suppressed.

本開示の実施の形態に係る漏液抑制装置を含む人工透析システムの構成を示す図である。1 is a diagram showing a configuration of an artificial dialysis system including a leakage prevention device according to an embodiment of the present disclosure. 図1に示す漏液抑制装置に含まれる検知部の構成を示す図である。2 is a diagram showing a configuration of a detection unit included in the liquid leakage prevention device shown in FIG. 1 . 図2に示す検知部を患者の穿刺部に設ける手順を示す図(その1)である。3A to 3C are diagrams (part 1) showing a procedure for providing the detection unit shown in FIG. 2 at the puncture site of a patient. 図2に示す検知部を患者の穿刺部に設ける手順を示す図(その2)である。3 is a diagram (part 2) showing the procedure for providing the detection unit shown in FIG. 2 at the puncture site of the patient. 図2に示す検知部を患者の穿刺部に設ける手順を示す図(その3)である。3 is a diagram (part 3) showing the procedure for providing the detection unit shown in FIG. 2 at the puncture site of the patient. 図2に示す検知部を患者の穿刺部に設ける手順を示す図(その4)である。4 is a diagram (part 4) showing the procedure for providing the detection unit shown in FIG. 2 at the puncture site of the patient. 図1に示す漏液抑制装置に含まれる開閉機構の構成を示す図(その1)である。2 is a diagram (part 1) showing the configuration of an opening and closing mechanism included in the leakage prevention device shown in FIG. 1 . 図1に示す漏液抑制装置に含まれる開閉機構の構成を示す図(その2)である。2 is a diagram (part 2) showing the configuration of the opening and closing mechanism included in the leakage prevention device shown in FIG. 1 . 図7,図8に示す開閉機構に含まれる駆動部としてのソレノイドを示す図(その1)である。FIG. 9 is a diagram (part 1) showing a solenoid as a drive unit included in the opening/closing mechanism shown in FIGS. 7 and 8 . 図7,図8に示す開閉機構に含まれる駆動部としてのソレノイドを示す図(その2)である。FIG. 9 is a second diagram showing a solenoid as a drive unit included in the opening/closing mechanism shown in FIGS. 7 and 8 . 図7,図8に示す開閉機構を血液回路上に設けた状態を示す図である。FIG. 9 is a diagram showing a state in which the opening and closing mechanism shown in FIGS. 7 and 8 is provided on a blood circuit. 図1に示す漏液抑制装置に含まれる制御部の構成を示す図である。2 is a diagram showing the configuration of a control unit included in the leakage prevention device shown in FIG. 1 .

以下に、本開示の実施の形態について説明する。なお、以下に説明する実施の形態において、個数、量などに言及する場合、特に記載がある場合を除き、本開示の範囲は必ずしもその個数、量などに限定されない。また、以下の実施の形態において、各々の構成要素は、特に記載がある場合を除き、本開示にとって必ずしも必須のものではない。 The following describes embodiments of the present disclosure. Note that in the embodiments described below, when numbers, amounts, etc. are mentioned, the scope of the present disclosure is not necessarily limited to those numbers, amounts, etc., unless otherwise specified. Furthermore, in the embodiments described below, each component is not necessarily essential to the present disclosure, unless otherwise specified.

図1は、人工透析システム100の構成を示す図である。図1に示すように、人工透析システム100は、ダイアライザ1と、透析液供給装置2と、血液回路3(導入液回路)と、血液ポンプ4と、抗凝固薬注入ポンプ5とを含む。 Figure 1 is a diagram showing the configuration of an artificial dialysis system 100. As shown in Figure 1, the artificial dialysis system 100 includes a dialyzer 1, a dialysis fluid supplying device 2, a blood circuit 3 (introducing fluid circuit), a blood pump 4, and an anticoagulant injection pump 5.

ダイアライザ1には、患者から取り出した血液(導入液)が送り込まれる。ダイアライザ1において、血液は、半透膜の孔を通じて血液と反対方向に流れる透析液と接触する。この際、尿素や老廃物など人体にとって有害な物質や余分な水分が、血液から透析液に移行し、電解質など身体に不足している物質が透析液から血液に補なわれる。 Blood (introducing fluid) taken from the patient is pumped into the dialyzer 1. In the dialyzer 1, the blood comes into contact with the dialysis fluid that flows in the opposite direction to the blood through the holes in the semipermeable membrane. During this process, substances harmful to the human body, such as urea and waste products, and excess water, are transferred from the blood to the dialysis fluid, and substances lacking in the body, such as electrolytes, are replenished from the dialysis fluid to the blood.

透析液供給装置2は、矢印DR2A方向に沿ってダイアライザ1に透析液を供給する。ダイアライザ1内を流れて血液と接触した老廃物を含む透析液は、矢印DR2B方向に沿って透析液供給装置2に戻される。 The dialysis fluid supplying device 2 supplies dialysis fluid to the dialyzer 1 in the direction of the arrow DR2A. The dialysis fluid containing waste products that flows through the dialyzer 1 and comes into contact with the blood is returned to the dialysis fluid supplying device 2 in the direction of the arrow DR2B.

血液回路3は、脱血側の血液回路3Aと、返血側の血液回路3Bとを含む。患者から取り出された血液は、矢印DR3A方向に沿って血液回路3Aを流れ、ダイアライザ1に達する。ダイアライザ1において浄化された血液は、矢印DR3B方向に沿って血液回路3Bを流れ、患者に返血される。 The blood circuit 3 includes a blood circuit 3A on the blood removal side and a blood circuit 3B on the blood return side. Blood taken from the patient flows through the blood circuit 3A in the direction of the arrow DR3A and reaches the dialyzer 1. Blood purified in the dialyzer 1 flows through the blood circuit 3B in the direction of the arrow DR3B and is returned to the patient.

血液ポンプ4は、血液回路3内に圧力をかけて、血液を循環させる。図1に示すように、血液ポンプ4は、脱血側の血液回路3A上に設けられる。 The blood pump 4 applies pressure to the blood circuit 3 to circulate the blood. As shown in FIG. 1, the blood pump 4 is provided on the blood circuit 3A on the blood removal side.

抗凝固薬注入ポンプ5は、脱血側の血液回路3Aに接続され、抗凝固薬を血液回路3Aに供給するものである。 The anticoagulant injection pump 5 is connected to the blood circuit 3A on the blood withdrawal side and supplies anticoagulant to the blood circuit 3A.

血液は、患者の穿刺部6(穿刺部6A)から脱血され、ダイアライザ1で浄化された後、患者の穿刺部6(穿刺部6B)に戻り、患者の体内に返血される。 Blood is withdrawn from the patient through the puncture site 6 (puncture site 6A), purified in the dialyzer 1, and then returned to the patient's puncture site 6 (puncture site 6B) and returned to the patient's body.

人工透析の治療中における穿刺部6からの血液漏れや針抜けを検知することが要請される。特に、治療中に返血側の穿刺部6Bにおいて針抜けが発生した場合、血液回路3を流れる血液が体外に流出することになる。かかる事態を迅速に検知するとともに、漏血を防止ないし最小限に抑制することが求められる。 It is necessary to detect blood leakage or needle dislodgement from the puncture site 6 during dialysis treatment. In particular, if needle dislodgement occurs at the puncture site 6B on the blood return side during treatment, blood flowing through the blood circuit 3 will flow out of the body. It is necessary to quickly detect such an event and prevent or minimize blood leakage.

本実施の形態に係る漏血抑制装置は、人工透析システム100に用いられるものであって、穿刺部6における漏血または針抜状態を検知可能な検知部10と、血液回路3上に設けられ、血液回路3を開閉可能な開閉機構20と、穿刺部6における漏血が検知部10により検知されたときに、開閉機構20により血液回路3を閉塞するように開閉機構を制御する制御部30とを備える。図1においては、図示の便宜上、開閉機構20を脱血側の血液回路3A上に設けられているが、1つの典型例において、開閉機構20は、返血側の血液回路3B上に設けられたチャンバ(図示せず)の下部(好ましくは直下)に取り付けられる。なお、開閉機構20の設置位置は上述の位置に限定されない。以下、検知部10、開閉機構20、および制御部30について説明する。 The blood leakage prevention device according to the present embodiment is used in an artificial dialysis system 100, and includes a detection unit 10 capable of detecting blood leakage or needle removal at the puncture unit 6, an opening/closing mechanism 20 provided on the blood circuit 3 and capable of opening and closing the blood circuit 3, and a control unit 30 that controls the opening/closing mechanism so that the opening/closing mechanism 20 closes the blood circuit 3 when blood leakage at the puncture unit 6 is detected by the detection unit 10. In FIG. 1, for convenience of illustration, the opening/closing mechanism 20 is provided on the blood circuit 3A on the blood removal side, but in one typical example, the opening/closing mechanism 20 is attached to the lower part (preferably directly below) of a chamber (not shown) provided on the blood circuit 3B on the blood return side. The installation position of the opening/closing mechanism 20 is not limited to the above-mentioned position. Below, the detection unit 10, the opening/closing mechanism 20, and the control unit 30 will be described.

図2は、検知部10の構成を示す図である。図2に示すように、検知部10は、センサ11と、パッド12と、粘着テープ13とを含む。粘着テープ13には、折り返し部分13Aが設けられている。検知部10は、脱血側の穿刺部6Aおよび返血側の穿刺部6Bの両方に設けられるが、場合により、穿刺部6A,6Bのうち片方にのみ設けられることもあり得る。 Figure 2 is a diagram showing the configuration of the detection unit 10. As shown in Figure 2, the detection unit 10 includes a sensor 11, a pad 12, and an adhesive tape 13. The adhesive tape 13 has a folded portion 13A. The detection unit 10 is provided in both the puncture portion 6A on the blood removal side and the puncture portion 6B on the blood return side, but in some cases it may be provided in only one of the puncture portions 6A, 6B.

センサ11は、たとえば銀やカーボンペーストなどの導電体から構成される。パッド12は、たとえば不織布により構成される。粘着テープ13は、たとえばレーヨン、合成繊維、アクリル系接着剤などから構成される。 The sensor 11 is made of a conductor such as silver or carbon paste. The pad 12 is made of nonwoven fabric. The adhesive tape 13 is made of rayon, synthetic fiber, acrylic adhesive, etc.

図3~図6は、検知部10を患者の穿刺部6に設ける手順を示す図である。まず、個包装された検知部10を開封し、図3に示すように、粘着テープ13の折り返し部分13Aを持ち、台紙14から剥がす。次に、図4に示すように、穿刺針7の穿刺部位(穿刺部6)にパッド12をあて、しっかりと密着させる。次に、図5に示すように、センサ11の一部をクリップ15により挟む。そして、図6に示すように、クリップ15を穿刺針7に取り付ける。クリップ15は、制御部30と電気的に接続されている。 Figures 3 to 6 are diagrams showing the procedure for installing the detection unit 10 at the puncture site 6 of a patient. First, the individually packaged detection unit 10 is opened, and as shown in Figure 3, the folded-back portion 13A of the adhesive tape 13 is held and peeled off from the backing 14. Next, as shown in Figure 4, the pad 12 is placed on the puncture site (puncture site 6) of the puncture needle 7 and firmly adhered. Next, as shown in Figure 5, a part of the sensor 11 is clamped by the clip 15. Then, as shown in Figure 6, the clip 15 is attached to the puncture needle 7. The clip 15 is electrically connected to the control unit 30.

上記検知部10により、穿刺部6からの血液漏れを検知することができる。また、穿刺針7が抜けた場合には、クリップ15がセンサ11から離脱して、針抜けを検知することができる。漏血や針抜状態が検知されたとき、開閉機構20により血液回路3が閉塞される。 The detection unit 10 can detect blood leakage from the puncture part 6. In addition, if the puncture needle 7 is removed, the clip 15 detaches from the sensor 11, making it possible to detect needle removal. When blood leakage or a needle removal state is detected, the blood circuit 3 is closed by the opening and closing mechanism 20.

図7,図8は、開閉機構20の構成を示す図である。図7は、通常時の開閉機構20を示し、図8は、異常時、すなわち穿刺部6における漏血または針抜状態が検知部10により検知されたときの開閉機構20を示す。図7,図8においては、血液回路3を図示していない。図7,図8に示すように、開閉機構20は、第1部材21と、第2部材22と、第3部材23と、弾性部材24と、ソレノイド25(駆動部)とを含む。 Figures 7 and 8 are diagrams showing the configuration of the opening and closing mechanism 20. Figure 7 shows the opening and closing mechanism 20 in normal operation, and Figure 8 shows the opening and closing mechanism 20 in an abnormal state, i.e., when blood leakage or needle removal at the puncture section 6 is detected by the detection section 10. The blood circuit 3 is not shown in Figures 7 and 8. As shown in Figures 7 and 8, the opening and closing mechanism 20 includes a first member 21, a second member 22, a third member 23, an elastic member 24, and a solenoid 25 (drive section).

第1部材21は、支持面21Aと、保持面21B,21C(第1面)とを有する。第2部材は、突起部22Aと、保持面22B,22C(第2面)とを有する。突起部22Aは、第3部材23に向かって突出する。保持面22B,22Cは、第1部材21の保持面21B,21Cとほぼ平行に形成される。第3部材23は、突起部23Aを有する。突起部23Aは、第2部材22の突起部22Aと対向する。 The first member 21 has a support surface 21A and holding surfaces 21B, 21C (first surface). The second member has a protrusion 22A and holding surfaces 22B, 22C (second surface). The protrusion 22A protrudes toward the third member 23. The holding surfaces 22B, 22C are formed approximately parallel to the holding surfaces 21B, 21C of the first member 21. The third member 23 has a protrusion 23A. The protrusion 23A faces the protrusion 22A of the second member 22.

弾性部材24は、第1部材21の支持面21Aと第2部材22との間に設けられる。弾性部材24は、保持面21B,21C(第1面)と保持面22B,22C(第2面)とを近づける方向に第1部材21および第2部材22を付勢する。通常時(図7)においては、弾性部材24の付勢力により、第1部材21の保持面21B,21Cと第2部材22の保持面22B,22Cとの間に血液回路3は保持される。すなわち、通常時において、血液回路3は、第1部材21の2箇所(保持面21B,21C)と、第2部材22の2箇所(保持面22B,22C)とで保持される。保持面21B,21C,22B,22Cは、通常時に血液回路3の流路を狭めて血液の流れを阻害しないよう、平面状に形成されている。 The elastic member 24 is provided between the support surface 21A of the first member 21 and the second member 22. The elastic member 24 biases the first member 21 and the second member 22 in a direction that brings the holding surfaces 21B, 21C (first surface) and the holding surfaces 22B, 22C (second surface) closer to each other. Under normal circumstances (FIG. 7), the blood circuit 3 is held between the holding surfaces 21B, 21C of the first member 21 and the holding surfaces 22B, 22C of the second member 22 by the biasing force of the elastic member 24. That is, under normal circumstances, the blood circuit 3 is held at two points (holding surfaces 21B, 21C) of the first member 21 and two points (holding surfaces 22B, 22C) of the second member 22. The holding surfaces 21B, 21C, 22B, 22C are formed in a planar shape so as not to narrow the flow path of the blood circuit 3 and obstruct the flow of blood under normal circumstances.

ソレノイド25(駆動部)は、第2部材22に近づく方向に第3部材23の突起部23Aを駆動することができる。穿刺部6における漏血または針抜状態が検知部10により検知されたとき、制御部30は、第3部材23の突起部23Aを第2部材22の突起部22Aに近づける方向に第3部材23を駆動する(図8)。これにより、血液回路3は、第2部材22の突起部22Aと第3部材23の突起部23Aとで挟持される。すなわち、穿刺部6における漏血または針抜状態が発生したとき、血液回路3は、第2部材22の1箇所(突起部22A)と、第3部材23の1箇所(突起部23A)とで挟持され、これにより、血液回路3が閉塞される。これにより、漏血を防止ないし最小限に抑制することができる。突起部22A,23Aの先端は、血液回路3を閉塞しやすいよう、尖った形状(応力集中が生じやすい形状)に形成されている。 The solenoid 25 (drive unit) can drive the protrusion 23A of the third member 23 in a direction approaching the second member 22. When the detection unit 10 detects blood leakage or a needle-removed state at the puncture portion 6, the control unit 30 drives the third member 23 in a direction that brings the protrusion 23A of the third member 23 closer to the protrusion 22A of the second member 22 (FIG. 8). As a result, the blood circuit 3 is clamped between the protrusion 22A of the second member 22 and the protrusion 23A of the third member 23. That is, when blood leakage or a needle-removed state occurs at the puncture portion 6, the blood circuit 3 is clamped between one point (protrusion 22A) of the second member 22 and one point (protrusion 23A) of the third member 23, thereby blocking the blood circuit 3. This makes it possible to prevent or minimize blood leakage. The tips of the protrusions 22A and 23A are formed with a pointed shape (a shape that is likely to cause stress concentration) to make it easier to block the blood circuit 3.

血液回路3が閉塞されると、血液回路3中の圧力が変動(上昇)する。このとき、血液ポンプ4は、その圧力の変動に基づいて動作を停止させる。この動作停止の機能は、従来の血液ポンプ4にも備えられている。よって、本実施の形態に係る漏血抑制装置は、既存の人工透析システム100にそのまま取り付けることができる。たとえば返血側の血液回路3B上に設けられたチャンバの下部に開閉機構20を取り付けた場合、血液回路3Bの閉塞に伴なって静脈側チャンバの圧力が上昇する。人工透析システム100において、静脈側チャンバの圧力は常に監視されているため、既存の設備を利用して圧力の上昇を検知することができる。血液回路3Bの圧力上昇が検知されたとき、血液ポンプ4の動作は停止する。 When the blood circuit 3 is blocked, the pressure in the blood circuit 3 fluctuates (rises). At this time, the blood pump 4 stops operating based on the pressure fluctuation. This function of stopping operation is also provided in conventional blood pumps 4. Therefore, the blood leakage prevention device of this embodiment can be directly installed in an existing artificial dialysis system 100. For example, if an opening and closing mechanism 20 is installed at the bottom of a chamber provided on the blood circuit 3B on the blood return side, the pressure in the venous chamber increases as the blood circuit 3B is blocked. In the artificial dialysis system 100, the pressure in the venous chamber is constantly monitored, so the increase in pressure can be detected using existing equipment. When an increase in pressure in the blood circuit 3B is detected, the operation of the blood pump 4 stops.

図9,図10は、ソレノイド25を示す図である。図9,図10に示すように、ソレノイド25は、棒状部材25Aと、コイル25Bとを含む。コイル25Bに電流が流れると、棒状部材25Aが軸方向に駆動され、第3部材23の突起部23Aが第2部材22の突起部22Aに近づく方向に第3部材23が駆動される。 Figures 9 and 10 are diagrams showing the solenoid 25. As shown in Figures 9 and 10, the solenoid 25 includes a rod-shaped member 25A and a coil 25B. When a current flows through the coil 25B, the rod-shaped member 25A is driven in the axial direction, and the third member 23 is driven in a direction in which the protrusion 23A of the third member 23 approaches the protrusion 22A of the second member 22.

図11は、開閉機構20を血液回路3上に設けた状態を示す図である。図11に示すように、通常時においては、弾性部材24の付勢力により第1部材21と第2部材22との間に血液回路3が保持されている。 Figure 11 is a diagram showing the state in which the opening and closing mechanism 20 is provided on the blood circuit 3. As shown in Figure 11, under normal circumstances, the blood circuit 3 is held between the first member 21 and the second member 22 by the biasing force of the elastic member 24.

図12は、制御部30の構成を示す図である。図12に示すように、制御部30は、マイコン31と、抵抗32(32A,32B)と、スイッチ回路33と、電源34とを含む。 Figure 12 is a diagram showing the configuration of the control unit 30. As shown in Figure 12, the control unit 30 includes a microcomputer 31, resistors 32 (32A, 32B), a switch circuit 33, and a power supply 34.

マイコン31は、検知部10のクリップ15と電気的に接続されている。マイコン31は、異常時(漏血ないし針抜状態)の信号を検知部10から受信し、予めプログラムされたパターンにより、ソレノイド25を駆動する指令を発信する。抵抗32を介してマイコン31に接続されたスイッチ回路33および電源34により、ソレノイド25が駆動される。 The microcomputer 31 is electrically connected to the clip 15 of the detection unit 10. The microcomputer 31 receives a signal from the detection unit 10 in the event of an abnormality (blood leakage or needle removal), and issues a command to drive the solenoid 25 according to a preprogrammed pattern. The solenoid 25 is driven by a switch circuit 33 and a power source 34 connected to the microcomputer 31 via a resistor 32.

本実施の形態に係る人工透析システム100によれば、液漏れ(漏血ないし針抜状態)の発生時に、血液の循環停止までを迅速に行ない、効果的に漏血を抑制することができる。 The artificial dialysis system 100 according to this embodiment can quickly stop blood circulation when leakage (blood leakage or needle dislodgement) occurs, effectively preventing blood leakage.

なお、本実施の形態においては、漏液抑制装置の一例として、人工透析システム100に用いられる漏血抑制装置について説明したが、漏液抑制装置はこれに限定されるものではなく、たとえば、輸液ポンプやシリンジポンプにおける漏液や抜針の監視にも同様の構成を適用可能である。 In this embodiment, a blood leakage prevention device used in the artificial dialysis system 100 has been described as an example of a blood leakage prevention device, but the blood leakage prevention device is not limited to this, and a similar configuration can be applied to, for example, monitoring blood leakage and needle removal in an infusion pump or a syringe pump.

以上、本開示の実施の形態について説明したが、今回開示された実施の形態はすべての点で例示であって制限的なものではないと考えられるべきである。本開示の範囲は特許請求の範囲によって示され、特許請求の範囲と均等の意味および範囲内でのすべての変更が含まれることが意図される。 Although the embodiments of the present disclosure have been described above, the embodiments disclosed herein should be considered to be illustrative in all respects and not restrictive. The scope of the present disclosure is defined by the claims, and is intended to include all modifications within the meaning and scope of the claims.

1 ダイアライザ、2 透析液供給装置、3,3A,3B 血液回路、4 血液ポンプ、5 抗凝固薬注入ポンプ、6,6A,6B 穿刺部、7 穿刺針、10 検知部、11 センサ、12 パッド、13 粘着テープ、13A 折り返し部分、14 台紙、15 クリップ、20 開閉機構、21 第1部材、21A 支持面、21B,21C 保持面、22 第2部材、22A 突起部、22B,22C 保持面、23 第3部材、23A 突起部、24 弾性部材、25 ソレノイド、25A 棒状部材、25B コイル、30 制御部、31 マイコン、32,32A,32B 抵抗、33 スイッチ回路、34 電源、100 人工透析システム。 1 Dialyzer, 2 Dialysis fluid supply device, 3, 3A, 3B Blood circuit, 4 Blood pump, 5 Anticoagulant injection pump, 6, 6A, 6B Puncture part, 7 Puncture needle, 10 Detection part, 11 Sensor, 12 Pad, 13 Adhesive tape, 13A Folded part, 14 Mounting paper, 15 Clip, 20 Opening and closing mechanism, 21 First member, 21A Support surface, 21B, 21C Holding surface, 22 Second member, 22A Protrusion, 22B, 22C Holding surface, 23 Third member, 23A Protrusion, 24 Elastic member, 25 Solenoid, 25A Rod-shaped member, 25B Coil, 30 Control unit, 31 Microcomputer, 32, 32A, 32B Resistor, 33 Switch circuit, 34 Power source, 100 Artificial dialysis system.

Claims (8)

患者の体外に設けられ、前記患者の体内に導入される導入液が流れる導入液回路を含むシステムに用いられる漏液抑制装置であって、
穿刺部における漏液または針抜状態を検知可能な検知部と、
前記導入液回路上に設けられ、前記導入液回路を開閉可能な開閉機構と、
前記穿刺部における漏液または針抜状態が前記検知部により検知されたときに、前記開閉機構により前記導入液回路を閉塞するように前記開閉機構を制御する制御部とを備え、
前記開閉機構は、
第1面を有する第1部材と、
前記第1面とほぼ平行な第2面を有する第2部材と、
前記第2部材と対向する部分を有する第3部材と、
前記第1部材と前記第2部材との間に設けられ、前記第1面と前記第2面とを近づける方向に前記第1部材および前記第2部材を付勢する弾性部材と、
前記第3部材における前記第2部材と対向する部分が前記第2部材に近づく方向に前記第3部材を駆動可能な駆動部とを含み、
通常時において、前記弾性部材の付勢力により前記第1面と前記第2面との間に前記導入液回路は保持され、
前記穿刺部における漏液または針抜状態が前記検知部により検知されたとき、前記第3部材が駆動され、前記第2部材と前記第3部材とで前記導入液回路を挟持して前記導入液回路を閉塞するように、前記制御部が前記駆動部を制御する、漏液抑制装置。
A leakage prevention device for use in a system including an introduction liquid circuit provided outside a patient's body and through which an introduction liquid to be introduced into the patient's body flows,
A detection unit capable of detecting leakage or needle removal at the puncture part;
an opening/closing mechanism provided on the introduction liquid circuit and capable of opening and closing the introduction liquid circuit;
a control unit that controls the opening and closing mechanism to close the introduction liquid circuit when the detection unit detects a liquid leakage or a needle removal state in the puncture unit ,
The opening and closing mechanism includes:
a first member having a first surface;
a second member having a second surface generally parallel to the first surface;
a third member having a portion facing the second member;
an elastic member provided between the first member and the second member and configured to bias the first member and the second member in a direction in which the first surface and the second surface approach each other;
a drive unit capable of driving the third member in a direction in which a portion of the third member facing the second member approaches the second member,
In a normal state, the introduction liquid circuit is held between the first surface and the second surface by the biasing force of the elastic member,
A leakage prevention device, in which, when the detection unit detects leakage or a needle withdrawal state at the puncture portion, the control unit controls the drive unit so that the third member is driven and the second member and the third member clamp the introduction liquid circuit to block the introduction liquid circuit .
前記開閉機構が前記導入液回路を閉塞したときの前記導入液回路の圧力の変動に基づいて、前記導入液回路に導入液を循環させる導入液ポンプが停止する、請求項1に記載の漏液抑制装置。 The leakage suppression device according to claim 1, wherein an introduction liquid pump that circulates the introduction liquid through the introduction liquid circuit is stopped based on a change in pressure in the introduction liquid circuit when the opening/closing mechanism closes the introduction liquid circuit. 前記開閉機構は、前記導入液ポンプよりも前記導入液回路の上流側に設けられる、請求項2に記載の漏液抑制装置。 The leakage prevention device according to claim 2, wherein the opening and closing mechanism is provided upstream of the liquid introduction circuit from the liquid introduction pump. 前記第1面および前記第2面は各々2箇所に分けて形成される、請求項1から請求項3のいずれかに記載の漏液抑制装置。 The leakage prevention device according to claim 1 , wherein the first surface and the second surface are each formed in two separate locations. 前記導入液回路は、前記患者の血液が流れる血液回路を含む、請求項1から請求項4のいずれかに記載の漏液抑制装置。 5. The leakage prevention device according to claim 1, wherein the introduction liquid circuit includes a blood circuit through which the patient's blood flows. 前記システムは、前記血液回路に接続されたダイアライザを含む人工透析システムである、請求項5に記載の漏液抑制装置。 6. The leakage prevention device according to claim 5 , wherein the system is an artificial dialysis system including a dialyzer connected to the blood circuit. 患者の体外に設けられ、前記患者の体内に導入される導入液が流れる導入液回路を閉塞可能な導入液回路閉塞装置であって、
第1面を有する第1部材と、
前記第1面とほぼ平行な第2面を有する第2部材と、
前記第2部材と対向する部分を有する第3部材と、
前記第1部材と前記第2部材との間に設けられ、前記第1面と前記第2面とを近づける方向に前記第1部材および前記第2部材を付勢する弾性部材と、
前記第3部材における前記第2部材と対向する部分が前記第2部材に近づく方向に前記第3部材を駆動可能な駆動部とを含み、
前記導入液回路が前記第1面と前記第2面との間に保持された状態から、前記第3部材が駆動され、前記第2部材と前記第3部材とで前記導入液回路を挟持して前記導入液回路を閉塞する、導入液回路閉塞装置。
An introduction liquid circuit blocking device that is provided outside a patient's body and is capable of blocking an introduction liquid circuit through which an introduction liquid to be introduced into the patient's body flows,
a first member having a first surface;
a second member having a second surface generally parallel to the first surface;
a third member having a portion facing the second member;
an elastic member provided between the first member and the second member and configured to bias the first member and the second member in a direction in which the first surface and the second surface approach each other;
a drive unit capable of driving the third member in a direction in which a portion of the third member facing the second member approaches the second member,
an introduction liquid circuit closing device, wherein the third member is driven from a state in which the introduction liquid circuit is held between the first surface and the second surface, and the introduction liquid circuit is clamped between the second member and the third member to close the introduction liquid circuit.
前記導入液回路は、前記患者の血液が流れる血液回路を含む、請求項7に記載の導入液回路閉塞装置。 The introduction fluid circuit occlusion device according to claim 7 , wherein the introduction fluid circuit includes a blood circuit through which the patient's blood flows.
JP2020031367A 2020-02-27 2020-02-27 Liquid leakage prevention device and liquid introduction circuit blocking device Active JP7463764B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020031367A JP7463764B2 (en) 2020-02-27 2020-02-27 Liquid leakage prevention device and liquid introduction circuit blocking device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020031367A JP7463764B2 (en) 2020-02-27 2020-02-27 Liquid leakage prevention device and liquid introduction circuit blocking device

Publications (2)

Publication Number Publication Date
JP2021132850A JP2021132850A (en) 2021-09-13
JP7463764B2 true JP7463764B2 (en) 2024-04-09

Family

ID=77662140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020031367A Active JP7463764B2 (en) 2020-02-27 2020-02-27 Liquid leakage prevention device and liquid introduction circuit blocking device

Country Status (1)

Country Link
JP (1) JP7463764B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900320C1 (en) 1999-01-07 2000-07-06 Fresenius Medical Care De Gmbh Safety valve for a flexible hose conduit, in particular, the venous blood conduit of a hemodialysis unit comprises bearing surfaces opposite to the blocking elements so that the hose can be blocked by either blocking element
JP2005525129A (en) 2001-07-07 2005-08-25 ネクステージ メディカル インコーポレイテッド METHOD AND APPARATUS FOR DETECTING FLUID LINE LEAK This application claims priority to US patent application Ser. No. 09 / 900,362, filed Jul. 7, 2001.
JP2010518907A (en) 2007-02-16 2010-06-03 バクスター・インターナショナル・インコーポレイテッド Improved signal detection for access disconnection systems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900320C1 (en) 1999-01-07 2000-07-06 Fresenius Medical Care De Gmbh Safety valve for a flexible hose conduit, in particular, the venous blood conduit of a hemodialysis unit comprises bearing surfaces opposite to the blocking elements so that the hose can be blocked by either blocking element
JP2005525129A (en) 2001-07-07 2005-08-25 ネクステージ メディカル インコーポレイテッド METHOD AND APPARATUS FOR DETECTING FLUID LINE LEAK This application claims priority to US patent application Ser. No. 09 / 900,362, filed Jul. 7, 2001.
JP2010518907A (en) 2007-02-16 2010-06-03 バクスター・インターナショナル・インコーポレイテッド Improved signal detection for access disconnection systems

Also Published As

Publication number Publication date
JP2021132850A (en) 2021-09-13

Similar Documents

Publication Publication Date Title
US8900173B2 (en) Blood purification apparatus
EP1425063B2 (en) System for leak detection in a fluid line
EP1025427B1 (en) Blood tubing set integrity test for extracorporeal circuits
KR101823070B1 (en) Moisture detection device for for use with a device for monitoring an access to a patient
JP4416797B2 (en) Improved method and apparatus for leak detection in blood processing systems
JP2009500108A (en) Blood leak monitoring method and apparatus
US20100234787A1 (en) Hemodialysis apparatus
US20130150768A1 (en) Blood Purification Apparatus And Method For Inspecting Liquid Leakage Thereof
CA2784524C (en) Apparatus for extracorporeal blood treatment and method of operation
US20170348471A1 (en) Medical apparatus
WO2003000315A1 (en) Needle dislodgement detection
US10314964B2 (en) Sterile tube covering for a medical tubing system
JPH0519423B2 (en)
JPH04253868A (en) Blood purifier
CN112218667A (en) Pressure detector
JP7463764B2 (en) Liquid leakage prevention device and liquid introduction circuit blocking device
JP4854374B2 (en) Extracorporeal circulation device, extracorporeal circulation circuit, method for confirming connection state of pressure measurement line and pressure measurement means
JP2010125131A (en) Calibration method of pressure measurement section
JP2007282928A5 (en)
JP2007215746A (en) Hemocatharsis apparatus and its leak check method
JP7039650B2 (en) Disposable equipment and extracorporeal blood treatment equipment for extracorporeal blood treatment, and how to confirm proper connection of lines
CN102215889A (en) Method and device for recognition of paravasal bleeding
JP6058252B2 (en) Blood purification apparatus and blood return method
JP2011030881A (en) Blood circuit and blood purifying apparatus equipped therewith
CN110461389B (en) Blood purification device, method for controlling same, and method for eliminating blood loss failure

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231221

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240311

R150 Certificate of patent or registration of utility model

Ref document number: 7463764

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150